These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3034316)

  • 1. The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure.
    Dickstein K; Till AE; Aarsland T; Tjelta K; Abrahamsen AM; Kristianson K; Gomez HJ; Gregg H; Hichens M
    Br J Clin Pharmacol; 1987 Apr; 23(4):403-10. PubMed ID: 3034316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of enalapril in congestive heart failure.
    Dickstein K
    Drugs; 1986; 32 Suppl 5():40-4. PubMed ID: 3032562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.
    Till AE; Dickstein K; Aarsland T; Gomez HJ; Gregg H; Hichens M
    Br J Clin Pharmacol; 1989 Feb; 27(2):199-204. PubMed ID: 2540786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of renal function on enalapril kinetics.
    Lowenthal DT; Irvin JD; Merrill D; Saris S; Ulm E; Goldstein S; Hichens M; Klein L; Till A; Harris K
    Clin Pharmacol Ther; 1985 Dec; 38(6):661-6. PubMed ID: 2998676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure.
    Nakamura H; Ishii M; Sugimura T; Chiba K; Kato H; Ishizaki T
    Clin Pharmacol Ther; 1994 Aug; 56(2):160-8. PubMed ID: 8062492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril: a review of human pharmacology.
    Gomez HJ; Cirillo VJ; Irvin JD
    Drugs; 1985; 30 Suppl 1():13-24. PubMed ID: 2994984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers.
    Till AE; Gomez HJ; Hichens M; Bolognese JA; McNabb WR; Brooks BA; Noormohamed F; Lant AF
    Biopharm Drug Dispos; 1984; 5(3):273-80. PubMed ID: 6091806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension.
    Schwartz JB; Taylor A; Abernethy D; O'Meara M; Farmer J; Young J; Nelson E; Pool J; Mitchell JR
    J Cardiovasc Pharmacol; 1985; 7(4):767-76. PubMed ID: 2410720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Hockings N; Ajayi AA; Reid JL
    Br J Clin Pharmacol; 1986 Apr; 21(4):341-8. PubMed ID: 3011046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of enalapril in normal subjects and patients with renal impairment.
    Kelly JG; Doyle G; Donohue J; Laher M; Vandenburg MJ; Currie WJ; Cooper WD
    Br J Clin Pharmacol; 1986 Jan; 21(1):63-9. PubMed ID: 3004546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and dynamics of enalapril in patients with liver cirrhosis.
    Ohnishi A; Tsuboi Y; Ishizaki T; Kubota K; Ohno T; Yoshida H; Kanezaki A; Tanaka T
    Clin Pharmacol Ther; 1989 Jun; 45(6):657-65. PubMed ID: 2543535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays.
    Arafat T; Awad R; Hamad M; Azzam R; Al-Nasan A; Jehanli A; Matalka K
    J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of the newer ACE inhibitors. A review.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1990 Sep; 19(3):177-96. PubMed ID: 2203579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of food on the bioavailability of enalapril.
    Swanson BN; Vlasses PH; Ferguson RK; Bergquist PA; Till AE; Irvin JD; Harris K
    J Pharm Sci; 1984 Nov; 73(11):1655-7. PubMed ID: 6097665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients.
    Weisser K; Schloos J; Jakob S; Mühlberg W; Platt D; Mutschler E
    Eur J Clin Pharmacol; 1992; 43(2):173-7. PubMed ID: 1330574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and metabolic aspects of enalapril action.
    Lant AF; McNabb RW; Noormohamed FH
    J Hypertens Suppl; 1984 Dec; 2(2):S37-42. PubMed ID: 6100875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
    Tarkiainen EK; Tornio A; Holmberg MT; Launiainen T; Neuvonen PJ; Backman JT; Niemi M
    Br J Clin Pharmacol; 2015 Nov; 80(5):1131-8. PubMed ID: 25919042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.